Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
PaperCitations, authors & open-access status
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 816 citations, 2017 year and closed oa status.
816
Citations
2017
Year
closed
OA Status